Page last updated: 2024-09-05

n(4)-adenosyl-n(4)-methyl-2,4-diaminobutanoic acid and Benign Neoplasms

n(4)-adenosyl-n(4)-methyl-2,4-diaminobutanoic acid has been researched along with Benign Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fischer, TR; Helm, M; Hoba, SN; Jung, N; Kersten, C; Koch, J; Lyko, F; Meidner, JL; Schirmeister, T; Schwickert, M; Stark, MM; Weber, M; Windbergs, M; Zimmermann, RA1

Other Studies

1 other study(ies) available for n(4)-adenosyl-n(4)-methyl-2,4-diaminobutanoic acid and Benign Neoplasms

ArticleYear
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer Treatment.
    Journal of medicinal chemistry, 2022, 07-28, Volume: 65, Issue:14

    Topics: Archaeal Proteins; Caco-2 Cells; DNA; Humans; Methyltransferases; Neoplasms; S-Adenosylhomocysteine; S-Adenosylmethionine

2022